These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 9395545)
21. Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes. Lopes AA; Port FK Am J Kidney Dis; 1995 May; 25(5):714-21. PubMed ID: 7747725 [TBL] [Abstract][Full Text] [Related]
22. Incidence of treatment for end-stage renal disease attributed to diabetes mellitus, by race/ethnicity--Colorado, 1982-1989. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1992 Nov; 41(44):845-8. PubMed ID: 1435671 [TBL] [Abstract][Full Text] [Related]
23. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. Choi AI; Rodriguez RA; Bacchetti P; Bertenthal D; Volberding PA; O'Hare AM J Am Soc Nephrol; 2007 Nov; 18(11):2968-74. PubMed ID: 17942954 [TBL] [Abstract][Full Text] [Related]
25. Neighborhood poverty and racial differences in ESRD incidence. Volkova N; McClellan W; Klein M; Flanders D; Kleinbaum D; Soucie JM; Presley R J Am Soc Nephrol; 2008 Feb; 19(2):356-64. PubMed ID: 18057219 [TBL] [Abstract][Full Text] [Related]
26. The conundrum of increased burden of end-stage renal disease in Asians. Hall YN; Hsu CY; Iribarren C; Darbinian J; McCulloch CE; Go AS Kidney Int; 2005 Nov; 68(5):2310-6. PubMed ID: 16221234 [TBL] [Abstract][Full Text] [Related]
27. Incidence of treatment for end-stage renal disease attributed to diabetes mellitus--United States, 1980-1989. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1992 Nov; 41(44):834-7. PubMed ID: 1435669 [TBL] [Abstract][Full Text] [Related]
28. Renal disease and black Americans: selected issues. Livingston IL Soc Sci Med; 1993 Sep; 37(5):613-21. PubMed ID: 8211275 [TBL] [Abstract][Full Text] [Related]
29. Racial factors in the incidence and causation of end-stage renal disease (ESRD). Easterling RE Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346 [TBL] [Abstract][Full Text] [Related]
30. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Freedman BI; Tuttle AB; Spray BJ Am J Kidney Dis; 1995 May; 25(5):710-3. PubMed ID: 7747724 [TBL] [Abstract][Full Text] [Related]
31. Racial disparities in access to simultaneous pancreas-kidney transplantation in the United States. Isaacs RB; Lobo PI; Nock SL; Hanson JA; Ojo AO; Pruett TL Am J Kidney Dis; 2000 Sep; 36(3):526-33. PubMed ID: 10977784 [TBL] [Abstract][Full Text] [Related]
32. Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project. Frankenfield DL; Rocco MV; Frederick PR; Pugh J; McClellan WM; Owen WF Am J Kidney Dis; 1999 Oct; 34(4):721-30. PubMed ID: 10516355 [TBL] [Abstract][Full Text] [Related]
33. Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients. Volkova N; McClellan W; Soucie JM; Schoolwerth A Nephrol Dial Transplant; 2006 Aug; 21(8):2202-9. PubMed ID: 16522661 [TBL] [Abstract][Full Text] [Related]
34. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. Hsu CY; Lin F; Vittinghoff E; Shlipak MG J Am Soc Nephrol; 2003 Nov; 14(11):2902-7. PubMed ID: 14569100 [TBL] [Abstract][Full Text] [Related]
35. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300 [TBL] [Abstract][Full Text] [Related]
36. Racial disparities in end-stage renal disease in a high-risk population: the Southern Community Cohort Study. Bock F; Stewart TG; Robinson-Cohen C; Morse J; Kabagambe EK; Cavanaugh KL; Birdwell KA; Hung AM; Abdel-Kader K; Siew ED; Akwo EA; Blot WJ; Ikizler TA; Lipworth L BMC Nephrol; 2019 Aug; 20(1):308. PubMed ID: 31390993 [TBL] [Abstract][Full Text] [Related]
37. Diagnosis of hypertensive end-stage renal disease: effect of patient's race. Perneger TV; Whelton PK; Klag MJ; Rossiter KA Am J Epidemiol; 1995 Jan; 141(1):10-5. PubMed ID: 7801960 [TBL] [Abstract][Full Text] [Related]
38. Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. O'Hare AM; Rodriguez RA; Hailpern SM; Larson EB; Kurella Tamura M JAMA; 2010 Jul; 304(2):180-6. PubMed ID: 20628131 [TBL] [Abstract][Full Text] [Related]
39. End-stage renal disease among HIV-infected adults in North America. Abraham AG; Althoff KN; Jing Y; Estrella MM; Kitahata MM; Wester CW; Bosch RJ; Crane H; Eron J; Gill MJ; Horberg MA; Justice AC; Klein M; Mayor AM; Moore RD; Palella FJ; Parikh CR; Silverberg MJ; Golub ET; Jacobson LP; Napravnik S; Lucas GM; Clin Infect Dis; 2015 Mar; 60(6):941-9. PubMed ID: 25409471 [TBL] [Abstract][Full Text] [Related]
40. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Derose SF; Rutkowski MP; Crooks PW; Shi JM; Wang JQ; Kalantar-Zadeh K; Kovesdy CP; Levin NW; Jacobsen SJ Am J Kidney Dis; 2013 Aug; 62(2):236-44. PubMed ID: 23499049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]